Exact Sciences
Healthcare Services · Wisconsin, United States · 6,500 Employees
View Company Info for Free
About
Headquarters
5505 Endeavor Ln, Madison, Wisconsin, 53719, Un...Phone Number
(608) 284-5700Website
www.exactsciences.comRevenue
$2.6 BillionStock Symbol
EXASIndustry
Most Recent Scoops
Highlights
$56M
Total Funding Amount
$56M
Most Recent Funding Amount
1
Number of Funding Rounds
Who is Exact Sciences
Exact Sciences Org Chart
Is Exact Sciences your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Exact Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Exact Sciences has new funding data
Check if Exact Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Exact Sciences had a recent Job posting/layoffs
Check out if Exact Sciences is spiking on competitors!
Product Launch: Get notified when Exact Sciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Exact Sciences
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Exact Sciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Exact Sciences
Compare insights from companies similar to Exact Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Exact Sciences
Exact Sciences Email Formats
Exact Sciences uses at least 5 email formats with first initials + last (ex. JSmith@exactsciences.com) being used 74.8% of the time
Exact Sciences Email Formats | Percentage | |
---|---|---|
first initials + last | JSmith@exactsciences.com | 74.8% |
first initials + last | JSmith@genomichealth.com | 11.1% |
first initials + middle initials + last | JLSmith@exactsciences.com | 7% |
first.last | John.Smith@exactsciences.com | |
first + last | JohnSmith@exactsciences.com |
Get Verified Emails
Exact Sciences financials insights
Gather financial insights about Exact Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Exact Sciences Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Exact Sciences Tech Stack
A closer look at the technologies used by Exact Sciences
Most Recent Scoops
Exact Sciences News & Media
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 11 abstracts at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) meeting January 23-25, 2025, in San Francisco. “The data we are presenting at ASCO GI underscore Exact Sciences’ leadership in advancing scientific innovation to drive meaningful progress in cancer detection and patient care,” said Jorge Garces, PhD, ch2 Healthcare Stocks to Buy Hand Over Fist in January
Instead, as long-term investors know, the key is to hold onto excellent companies that can perform well over the long run. Let's consider two in the healthcare sector: DexCom (NASDAQ: DXCM) and Exact Sciences (NASDAQ: EXAS). Let's discuss why these two companies are worth investing in right now.Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company expects to report revenue of $713 million for the fourth quarter ended December 31, 2024. "The Exact Sciences team delivered strong results to finish 2024, setting us up for sustained growth and profitability in the years to come," said Kevin Conroy, chairman and CEO. "We look forward to expanding our impact as the platformExact Sciences Corp (EXAS) Announces Participation in J.P. Morga - GuruFocus
Exact Sciences Corp (EXAS), a prominent provider of cancer screening and diagnostic tests, has announced its participation in the J.P. Morgan Healthcare Confere
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Exact Sciences
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; O... Read More